[Hypolipidemic, anti-oxidant and anticoagulant action of camphor-25 compound].
Pharmacotherapeutic efficacy, anti-oxidant and anti-coagulant activity of camphor compound was tested in animals with experimental dyslipoproteinemia. Positive results of the experiment allows recommending this compound for prevention of an atherosclerotic damage of vascular endothelium and against thrombogenesis.
Azhunova
T A
TA
Nikolaev
S M
SM
Buraeva
L B
LB
Dashiev
D B
DB
Banzaraksheeva
S A
SA
D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology*; D000975:Antioxidants / Q000494:pharmacology*; D050197:Atherosclerosis / Q000378:metabolism / Q000517:prevention & control*; D002164:Camphor / Q000494:pharmacology; D050171:Dyslipidemias / Q000188:drug therapy* / Q000378:metabolism; D004730:Endothelium, Vascular / Q000378:metabolism; D008297:Male; D010936:Plant Extracts / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D013927:Thrombosis / Q000188:drug therapy / Q000378:metabolism
D000925:Anticoagulants; D000975:Antioxidants; D010936:Plant Extracts; D002164:Camphor